Literature DB >> 1928581

A prospective clinicopathologic study of venous invasion in colorectal cancer.

K Shirouzu1, H Isomoto, T Kakegawa, M Morimatsu.   

Abstract

We performed a long-term prospective study on venous invasion of colorectal cancer. The degree of venous invasion was divided into four stages (V0 through V3). Venous invasion was classified into three types by location (Vx, Vy, and Vz). Hepatic metastasis occurred in 27%, 33%, and 20% of patients with V2, V3, and Vz tumors, respectively. Local recurrence occurred in 33% and 15% of the V3 and Vz groups, respectively. However, there were no significant differences among the groups in terms of the rate of pulmonary metastasis. The 6-year survival rate for Dukes' stage B tumors was 94%, 88%, and 74% in the V0, V1, and V2 groups, respectively. There was a significant difference in the survival rate between patients with V0 tumors and V2 and V3 tumors. However, no significant difference was noted in the location. In Dukes' stage C tumors, on the other hand, the survival rate was 77%, 56%, and 44% in the V1, V2, and V3 groups, respectively. Also, it was 85%, 73%, and 45% in Vx, Vy, and Vz cases, respectively. Significant differences were noted between V1 and V3 (or V2), and between Vz and Vx (or Vy). It appears that the degree and location of venous invasion influence not only hepatic metastasis, local recurrence, and survival rates but also have prognostic value.

Entities:  

Mesh:

Year:  1991        PMID: 1928581     DOI: 10.1016/0002-9610(91)90073-m

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  18 in total

1.  The benefits of elastic[corrected]--no stretch of the imagination [corrected].

Authors:  G Smith; N Waddell; A Riley
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

2.  Impact of using elastic stains for detection of venous invasion in the prognosis of patients with lymph node negative colorectal cancer.

Authors:  Daniel Baumhoer; Thore Thiesler; Christoph A Maurer; Andreas Huber; Gieri Cathomas
Journal:  Int J Colorectal Dis       Date:  2010-02-09       Impact factor: 2.571

3.  Detection of venous invasion in surgical specimens of colorectal carcinoma: the efficacy of various types of tissue blocks.

Authors:  A Sternberg; A Mizrahi; M Amar; G Groisman
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

4.  Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas.

Authors:  Yosuke Okamoto; Hiroyuki Mitomi; Kazuhito Ichikawa; Shigeki Tomita; Takahiro Fujimori; Yoshinori Igarashi
Journal:  Int J Clin Oncol       Date:  2014-12-09       Impact factor: 3.402

5.  Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes.

Authors:  Hsiang-Lin Tsai; Yung-Sung Yeh; Fang-Jung Yu; Chien-Yu Lu; Chin-Fan Chen; Chao-Wen Chen; Yu-Tang Chang; Jaw-Yuan Wang
Journal:  Int J Colorectal Dis       Date:  2008-10-14       Impact factor: 2.571

6.  Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis.

Authors:  Shu-Qiang Yue; Yan-Ling Yang; Ke-Feng Dou; Kai-Zong Li
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 7.  Proforma-based reporting in rectal cancer.

Authors:  F Taylor; N Mangat; I R Swift; G Brown
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

8.  Surgical treatment of lower rectal cancer with sphincter preservation using handsewn coloanal anastomosis.

Authors:  Y Nagamatsu; K Shirouzu; H Isomoto; Y Ogata; I Tsuchida; Y Akagi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  The value of an elastic tissue stain in detecting venous invasion in colorectal cancer.

Authors:  D G Vass; R Ainsworth; J H Anderson; D Murray; A K Foulis
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

Review 10.  MRI in local staging of rectal cancer: an update.

Authors:  Umit Tapan; Mustafa Ozbayrak; Servet Tatlı
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.